Issue Date: September 6, 2010
Policing The Pharma Supply Chain
Two years after adulterated heparin produced in China killed 81 people in the U.S., Western drug companies, their ingredient suppliers, and regulatory agencies are aligning efforts against unsafe imports. Sources in all quarters agree that the heparin case heightened public awareness of a safety threat and provided a wake-up call to drugmakers, the U.S. Food & Drug Administration, and other regulators. But guarding the global pharmaceutical supply chain against contaminated or unsafe ingredients . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society